Harvey Schonwald
Corporate Officer/Principal at Lakewood-Amedex, Inc.
Network origin in Harvey Schonwald first degree
Entity | Entity type | Industry | |
---|---|---|---|
Lakewood-Amedex, Inc.
Lakewood-Amedex, Inc. Pharmaceuticals: MajorHealth Technology Lakewood-Amedex, Inc. engages in the development of treatment for serious infectious diseases. Its product pipeline include Nu-3 cDFU, Nu-3 Oral Mucositis, Nu-8 cUTI, and Nu-8 (Cystic Fibrosis). The company is headquartered in Sarasota, FL.
6
| Private Company | Pharmaceuticals: Major | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Harvey Schonwald via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member | |
KEYCORP | Major Banks | Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
Wildwood Capital LLC
Wildwood Capital LLC Investment Banks/BrokersFinance Wildwood Capital LLC provides investment banking services. The company offers both financial and strategic advisory services to growth-oriented companies. It assists companies by properly blending their operating objectives with the appropriate financial structure in order to advance the principal mission of maximizing shareholder value. Wildwood Capital is headquartered in New York City, NY. | Investment Banks/Brokers | Chief Executive Officer | |
ACLARIS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
BIOTA HOLDINGS LTD. | Pharmaceuticals: Major | Director/Board Member | |
TMM, INC. | Information Technology Services | Director/Board Member | |
University of Cambridge | College/University | Graduate Degree | |
Parke Davis Pty Ltd.
Parke Davis Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke Davis Pty Ltd. is an Australian pharmaceutical company. The company is based in Caringbah, Australia. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Warner Lambert (UK) Ltd.
Warner Lambert (UK) Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Warner Lambert (UK) Ltd. is a manufacturer and wholesaler of pharmaceuticals and over the counter medicines. The company is based in Eastleigh, UK. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
University of Ottawa | College/University | Doctorate Degree | |
AlphaVax, Inc.
AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Chairman | |
University of St. Gallen | College/University | Undergraduate Degree | |
University of Birmingham | College/University | Undergraduate Degree | |
Georgetown University | College/University | Corporate Officer/Principal | |
Monsanto Australia Pty Ltd.
Monsanto Australia Pty Ltd. Wholesale DistributorsDistribution Services Monsanto Australia Pty Ltd. develops and distributes agricultural products. The firm products include Canola, Cotton and Vegetable Seeds. The company was founded in 1928 and is headquartered in Melbourne, Australia. | Wholesale Distributors | Corporate Officer/Principal | |
New York Academy of Sciences
New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Chairman | |
Alpha Omega Alpha Honor Medical Society
Alpha Omega Alpha Honor Medical Society Miscellaneous Commercial ServicesCommercial Services Alpha Omega Alpha Honor Medical Society is a national medical honor society founded in 1902. The non-profit company is based in Menlo Park, CA. The society's mission is to foster the development of the next generation of medical researchers by recognizing high educational achievement, honoring gifted teaching, encouraging the development of leaders in academia and the community, and supporting the improvement of care for all. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Critical Path Institute
Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Chairman | |
Cibus US LLC
Cibus US LLC BiotechnologyHealth Technology Cibus Genetics LLC is a biotechnology company. It develops products in agriculture and specialty chemicals. The company was founded by Peter Beetham in 2001 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
Auven Therapeutics Management LLLP
Auven Therapeutics Management LLLP Investment ManagersFinance Founded in 2007 by Stephen Evans-Freke and Peter Corr, Auven Therapeutics Management LLLP is a global private equity firm located in St. Thomas, Virgin Islands. They also have operations in New York City and Europe. The firm was formerly known as Celtic Therapeutics Management, which was the successor firm to Celtic Pharma Management LP. | Investment Managers | Founder | |
Red Sky Partners LLC | Corporate Officer/Principal | ||
InSphero AG
InSphero AG BiotechnologyHealth Technology InSphero AG supplies organotypic 3D microtissues for efficiency testing and toxicology in drug development. It offers 3D insight Islet, 3D InSight Tumor, Gravity TRAP ULA Plates, Cytotoxicity Assay Kit, 3D InSight in Vitro Toxixology services, imaging and automation. he company was founded by Jan Lichtenberg, Jens M. Kelm, Simon P. Hoerstrup and Wolfgang Moritz on March 26, 2009 and is headquartered in Schlieren, Switzerland. | Biotechnology | Director/Board Member | |
RPG LIFE SCIENCES LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
Celleron Therapeutics Ltd.
Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. The company has deep relationships with Oxford University and is located on the Oxford Science Park. Celleron is focused on developing new and innovative therapies to treat cancer, with a particular emphasis on clinical development. The British company is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. Celleron's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company was founded in 2004 and is led by CEO Nick la Thangue. | Pharmaceuticals: Major | Director/Board Member | |
IOM's Forum | Corporate Officer/Principal | ||
Patheon Biologics LLC
Patheon Biologics LLC BiotechnologyHealth Technology Patheon Biologics LLC manufactures, supplies clinical and commercial bulk biologics to the biopharmaceutical industry. The company was founded in 2010 and is headquartered in Jefferson City, MO. | Biotechnology | Director/Board Member | |
ADC THERAPEUTICS SA | Pharmaceuticals: Major | Chairman Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin | |
Beacon Street Advisors LLC
Beacon Street Advisors LLC Miscellaneous Commercial ServicesCommercial Services Beacon Street Advisors LLC provides financial services. The company is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Invictus Group LLC
Invictus Group LLC Data Processing ServicesTechnology Services Invictus Group LLC operates as a data-driven strategic advisory firm. It offers mergers and acquisitions, stress testing and capital planning, and BankGenome™ Project. The company was founded by Leonard J. DeRoma, Kamal Mustafa and Adam Mustafa in 2008 and is headquartered in Tyson, VA. | Data Processing Services | Founder | |
Stade Français Paris SA
Stade Français Paris SA Movies/EntertainmentConsumer Services Stade Français Paris SA owns and operates rugby union club. It offers rugby training for professionals, non-professionals, and children. The company was founded in in May 1995 and is headquartered in Paris, France. | Movies/Entertainment | Director/Board Member | |
Kleo Pharmaceuticals, Inc.
Kleo Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Kleo Pharmaceuticals, Inc. is a biotechnology company, which engages in the development of biospecific compounds designed to emulate and enhance the activity of biologics. Its compounds are designed to direct the immune system to destroy cancerous or virally infected cells, and treatment of multiple myeloma and COVID-19. It offers Antibody Recruiting Molecules (ARMs),Synthetic Antibody Mimics (SyAMs), and Monoclonal Antibody Therapy Enhancers (MATEs) pipeline. The company was founded by David A. Spiegel and Roy Prieb in 2015 and is headquartered in New Haven, CT. | Miscellaneous Commercial Services | Chief Executive Officer | |
ImVax, Inc.
ImVax, Inc. BiotechnologyHealth Technology ImVax, Inc. provides healthcare services. The company was founded in 2015 and is headquartered in Philadelphia, PA. | Biotechnology | Founder Director/Board Member | |
VAXART, INC. | Biotechnology | Director/Board Member | |
ADC Therapeutics (UK) Ltd.
ADC Therapeutics (UK) Ltd. BiotechnologyHealth Technology Part of ADC Therapeutics SA, ADC Therapeutics (UK) Ltd. is a British company that provides research and experimental development in biotechnology. The company is based in Reading, UK and was founded in 2014. | Biotechnology | Director/Board Member | |
Flare Therapeutics, Inc.
Flare Therapeutics, Inc. BiotechnologyHealth Technology Flare Therapeutics is a biotechnology company that focuses on drugging transcription factors to develop small molecule medicines. The company is based in Cambridge, MA. The company's integrated discovery engine converges genetic, biochemical, and chemical insights to reveal druggable pockets and identify small molecule ligands capable of modulating transcription factors of high therapeutic potential. Flare's proteomic and mass spectrometry platform is powered by a proprietary library of electrophilic compounds unique to the company. The team has rapidly established an emerging pipeline of programs, highlighted by FX-909, a first-in-class investigational orally bioavailable small molecule inhibitor of PPARG, a master regulator of the luminal lineage in advanced urothelial cancer that has entered the clinic. Flare Therapeutics was launched in 2021 and is backed by founding investor Third Rock Ventures, as well as Boxer Capital, Nextech Invest, Casdin Capital, Invus Financial Advisors, and Eventide Asset Management. The company was founded by Mitchell Lazar, Fraydoon Rastinejad, Robert J. Sims, and Steven L. McKnight. Amit Rakhit has been the CEO of the company since 2022. | Biotechnology | Chief Executive Officer | |
Sermonix Pharmaceuticals LLC
Sermonix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Sermonix Pharmaceuticals LLC operates as a pharmaceutical company that focuses on the development and commercialization of late-stage women?s health products. It offers lasofoxifene, a selective estrogen receptor modulator for the treatment of vulvovaginal atrophy, as well as treatment and prevention of post-menopausal osteoporosis. The company was founded in 2014 by David Portman and is headquartered in Columbus, OH. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
United States | 32 |
United Kingdom | 6 |
Australia | 5 |
Switzerland | 5 |
Canada | 4 |
Sectoral
Health Technology | 25 |
Commercial Services | 8 |
Consumer Services | 8 |
Finance | 7 |
Technology Services | 3 |
Operational
Director/Board Member | 35 |
Corporate Officer/Principal | 16 |
Chairman | 14 |
Chief Executive Officer | 8 |
Independent Dir/Board Member | 7 |
Most connected contacts
Insiders | |
---|---|
Peter Corr | 28 |
Geoffrey F. Cox | 20 |
Leonard J. DeRoma | 10 |
Thomas Pfisterer | 10 |
Douglas Manion | 8 |
Charles Frederick Wright | 1 |
- Stock Market
- Insiders
- Harvey Schonwald
- Company connections